ClinicalTrials.Veeva
Menu

Find clinical trials for Lung Cancer in St Louis, MO

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Small Cell Lung Carcinoma
Cancer
Colorectal Cancer
Neoplasm Metastasis
Breast Cancer
Squamous Cell Carcinoma of Head and Neck

Lung Cancer trials near St Louis, MO, USA:

Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial)

Although small cell lung cancer (SCLC) responds dramatically to initial platinum-based chemotherapy, recurrences are nearly univers...

Enrolling
Small-cell Lung Cancer
Small Cell Lung Cancer
Drug: Cirtuvivint
Drug: Irinotecan

Phase 1, Phase 2

The Washington University
The Washington University

St Louis, Missouri, United States

Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment

Inhibitor( TKI) , to recurrent, advanced, or metastatic small cell lung cancer (SCLC) patients , Non-Small Cell Lung (NSCL...

Enrolling
Small Cell Lung Cancer
Non-Small Cell Lung
Drug: AL8326 40 mg
Drug: AL8326 60 mg

Phase 2

Advenchen

St Louis, Missouri, United States and 6 other locations

Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node or Other High Risk Features (NEO-SURG)

by resection and adjuvant cemiplimab in stage 3 non-small cell lung cancer (NSCLC) with select N3 lymph node involvement or other h...

Enrolling
Non-small Cell Lung Cancer Stage III
Drug: Cemiplimab-Rwlc

Phase 2

Georgetown University
Georgetown University

St Louis, Missouri, United States and 2 other locations

A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)

HCC is a common cancer worldwide and a leading cause of cancer-related death. Lung cancer is the most frequently ...

Enrolling
Hepatocellular Cancer
Squamous-Cell Non-Small Cell Lung Cancer
Drug: ABBV-324
Drug: Lenvatinib

Phase 1

AbbVie
AbbVie

St Louis, Missouri, United States and 21 other locations

Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy

This is a Phase II, multi-site, open-label, parallel group study in participants with untreated extended-stage small-cell lung cancer...

Active, not recruiting
Small-cell Lung Cancer
Extensive-stage Small-cell Lung Cancer
Drug: Paclitaxel
Drug: BNT327 Dose Level 2 (DL2)

Phase 2

BioNTech
BioNTech

Fenton, Missouri, United States and 64 other locations

DSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer

with atezolizumab in patients with extensive stage small cell lung cancer (ES-SCLC) whose disease has not progressed after initial ...

Enrolling
Small-cell Lung Cancer
Small Cell Lung Cancer Extensive Stage
Drug: Atezolizumab
Drug: DSP-0390

Phase 1

The Washington University
The Washington University

St Louis, Missouri, United States

First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) in Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer (FLINN)

This is a single center, phase Ib/II study combining an anti-PD-1 antibody and an anti-CTLA-4 antibody with IL-15. It is testing the hypothesis that...

Enrolling
Non-small Cell Lung Cancer Stage IV
Non-small Cell Lung Cancer Recurrent
Drug: Nivolumab
Drug: Ipilimumab

Phase 1, Phase 2

The Washington University
The Washington University

St Louis, Missouri, United States

Study of Novel Treatment Combinations in Patients With Lung Cancer (VELOCITY-Lung)

The goal of this platform clinical trial is to test how well novel treatment combinations work in participants with lung cancer. Su ...

Active, not recruiting
Resectable Non-Small-Cell Lung Cancer
Lung Cancer
Drug: Paclitaxel
Drug: Carboplatin

Phase 2

Gilead Sciences
Gilead Sciences

St Louis, Missouri, United States and 88 other locations

Ifinatamab Deruxtecan (I-DXd) in Subjects With Pretreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (IDeate-Lung01)

results observed in participants with Extensive-stage Small Cell Lung Cancer (ES-SCLC) who received at least 1 prior line of platin...

Active, not recruiting
Extensive-stage Small-cell Lung Cancer
Drug: Ifinatamab Deruxtecan (I-DXd)

Phase 2

Daiichi Sankyo
Daiichi Sankyo

St Louis, Missouri, United States and 57 other locations

Study of Tarlatamab in Combination With YL201 With or Without Anti-programmed Death Ligand 1 (PD-L1) in Participants With Extensive Stage (ES) Small Cell Lung Cancer (SCLC) ((DeLLphi-310))

The primary objective of this study is to evaluate the safety and tolerability of tarlatamab in combination with YL201 with or without anti-PD-L1.

Active, not recruiting
Small Cell Lung Cancer
Drug: Tarlatamab
Drug: Durvalumab

Phase 1

Amgen
Amgen

St Louis, Missouri, United States and 35 other locations

Clinical trials

Find clinical trialsTrials by location

Research sites

Find research sitesLearn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy NoticeTerms
© Copyright 2026 Veeva Systems